Psychiatry and Neurology, Neurology · Dallas, TX
NPI
1659719888
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8390 Lyndon B Johnson Fwy Ste 1000
Dallas, TX, 75243
Phone (214) 590-8058
Groups this clinician bills Medicare through
Medicare paid, 2024
$507K
54,096 services
Medicare patients, 2024
656
Average age 76
Drug cost, 2024
$2.1M
4,145 prescriptions
Company payments, 2025
$849
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth J Chambers was code J0585 (injection, onabotulinumtoxina, 1 unit), 41,874 times for 62 patients. In total Elizabeth J Chambers billed 54,096 services in 80 codes, and Medicare paid $507K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 41,874 | 62 | $4.94 | $207K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 1,325 | 14 | $9.28 | $12K |
| 97112 PT Treatment | Office | 800 | 47 | $21.37 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 737 | 455 | $12.19 | $8,986 |
| 99215 Office E&M - Established | Office | 499 | 306 | $126.50 | $63K |
| 97110 PT Treatment | Office | 482 | 50 | $16.56 | $7,984 |
| 97530 PT Treatment | Office | 389 | 46 | $23.41 | $9,108 |
| 99214 Office E&M - Established | Office | 315 | 242 | $89.50 | $28K |
| 95874 Musculoskeletal | Office | 164 | 54 | $59.43 | $9,747 |
| 97150 PT Treatment | Office | 147 | 41 | $10.51 | $1,544 |
| 92507 Speech Therapy | Office | 132 | 17 | $52.70 | $6,957 |
| 97116 PT Treatment | Office | 132 | 24 | $16.90 | $2,231 |
| 97140 PT Treatment | Office | 113 | 22 | $15.89 | $1,796 |
| 64616 Musculoskeletal | Office | 112 | 37 | $121.47 | $14K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 101 | 18 | $48.00 | $4,848 |
By year: 2022 $289K for 18,746 services; 2023 $453K for 35,467 services; 2024 $507K for 54,096 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth J Chambers prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 811 prescriptions and refills. In total Elizabeth J Chambers wrote 4,145 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 811 | 1,752 | 238 | $29K |
| Rytary Carbidopa/Levodopa | 723 | 1,285 | 144 | $872K |
| Donepezil Hcl Generic | 371 | 806 | 104 | $4,639 |
| Gabapentin Generic | 211 | 372 | 75 | $3,761 |
| Memantine Hcl Generic | 184 | 373 | 55 | $5,009 |
| Sertraline Hcl Generic | 166 | 356 | 54 | $1,402 |
| Primidone Generic | 114 | 240 | 34 | $4,588 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 99 | 217 | 34 | $5,159 |
| Quetiapine Fumarate Generic | 95 | 146 | 25 | $1,601 |
| Rivastigmine Generic | 82 | 175 | 24 | $21K |
| Rasagiline Mesylate Generic | 80 | 181 | 21 | $13K |
| Escitalopram Oxalate Generic | 75 | 116 | 16 | $522 |
| Amantadine Amantadine Hcl | 70 | 148 | 26 | $4,064 |
| Propranolol Hcl Er Propranolol Hcl | 64 | 106 | 18 | $1,402 |
| Levetiracetam Generic | 64 | 143 | 17 | $2,724 |
Brand drugs: - claims; generic drugs: 3,086 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elizabeth J Chambers $849 ($849 in general payments such as food, travel and fees) from 21 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $165.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $165 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $90.9 |
| Biogen, Inc. BIIB | 3 | $66.84 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $57.96 |
| Abbvie Inc. ABBV | 2 | $38.04 |
| UCB, Inc. UCB.BR | 2 | $37.65 |
| Eisai Inc. 4523.T | 1 | $37.47 |
| Argenx US, Inc. ARGX | 1 | $33.78 |
| Immedica Pharma US, Inc. | 1 | $33.66 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $31.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.